THMO - ThermoGenesis Holdings, Inc.
Previous close
0.3102
0.310 100.000%
Share volume: 0
Last Updated: Fri 14 Jun 2024 08:05:14 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | |
Report Date | 2022-05-20 | 2022-08-11 | 2022-11-10 | |
Total revenue | 2.663 M | 3.029 M | 2.115 M | |
Cost of revenue | 1.723 M | 2.090 M | 1.678 M | |
Gross profit | 940.000 K | 939.000 K | 437.000 K | |
-0.11% | -53.46% | |||
Operating expenses | 2.149 M | 2.381 M | 2.452 M | |
Selling general and admin | 1.693 M | 1.989 M | 1.982 M | |
Research and development | 456.000 K | 392.000 K | 470.000 K | |
Total expenses | 3.872 M | 4.471 M | 4.130 M | |
15.47% | -7.63% | |||
Operating income | -1.209 M | -1.442 M | -2.015 M | |
Ebit | -1.209 M | -1.442 M | -2.015 M | |
Pretax income | -2.036 M | -2.801 M | -3.403 M | |
37.57% | 21.49% | |||
Income tax | 0.000 | 0.000 | 0.000 | |
Net income basic | -1.910 M | -2.688 M | -3.240 M | |
-40.73% | -20.54% | |||
Net income | -1.910 M | -2.688 M | -3.240 M | |
-40.73% | -20.54% |